BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19351300)

  • 1. The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis.
    Couper JW; Love AW; Dunai JV; Duchesne GM; Bloch S; Costello AJ; Kissane DW
    Med J Aust; 2009 Apr; 190(S7):S86-9. PubMed ID: 19351300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of psychosocial distress 12 months after diagnosis with early and advanced prostate cancer.
    Couper JW; Love AW; Duchesne GM; Bloch S; Macvean M; Dunai JV; Scealy M; Costello A; Kissane DW
    Med J Aust; 2010 Sep; 193(S5):S58-61. PubMed ID: 21542448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
    Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
    BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
    Punnen S; Cowan JE; Dunn LB; Shumay DM; Carroll PR; Cooperberg MR
    BJU Int; 2013 Jul; 112(2):E67-75. PubMed ID: 23795800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
    Jeldres C; Cullen J; Hurwitz LM; Wolff EM; Levie KE; Odem-Davis K; Johnston RB; Pham KN; Rosner IL; Brand TC; L'Esperance JO; Sterbis JR; Etzioni R; Porter CR
    Cancer; 2015 Jul; 121(14):2465-73. PubMed ID: 25845467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
    Houédé N; Rébillard X; Bouvet S; Kabani S; Fabbro-Peray P; Trétarre B; Ménégaux F
    BMC Cancer; 2020 Aug; 20(1):757. PubMed ID: 32787797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.
    Caumont F; Conti G; Hurwitz LM; Kuo C; Levie KE; Badiozamani K; Frankel JK; Flores JP; Brand TC; Chaurasia A; Rosner IL; Stroup SP; Musser JE; Cullen J; Porter CR
    Urol Oncol; 2020 Oct; 38(10):794.e1-794.e9. PubMed ID: 32139288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy versus watchful waiting for prostate cancer.
    Hegarty J; Beirne PV; Walsh E; Comber H; Fitzgerald T; Wallace Kazer M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006590. PubMed ID: 21069689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-physician communication and health-related quality of life of patients with localised prostate cancer undergoing radical prostatectomy - a longitudinal multilevel analysis.
    Ernstmann N; Weissbach L; Herden J; Winter N; Ansmann L
    BJU Int; 2017 Mar; 119(3):396-405. PubMed ID: 27037732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.